Compare TXO & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TXO | LENZ |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 687.5M | 609.5M |
| IPO Year | 2022 | 2021 |
| Metric | TXO | LENZ |
|---|---|---|
| Price | $12.29 | $12.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $20.50 | ★ $56.25 |
| AVG Volume (30 Days) | 192.2K | ★ 714.1K |
| Earning Date | 01-01-0001 | 04-16-2026 |
| Dividend Yield | ★ 13.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $401,012,000.00 | N/A |
| Revenue This Year | $15.64 | N/A |
| Revenue Next Year | N/A | $157.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 41.80 | N/A |
| 52 Week Low | $10.12 | $11.48 |
| 52 Week High | $20.24 | $50.19 |
| Indicator | TXO | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 36.65 |
| Support Level | $11.85 | $11.48 |
| Resistance Level | $12.94 | $14.97 |
| Average True Range (ATR) | 0.32 | 0.90 |
| MACD | -0.07 | 0.11 |
| Stochastic Oscillator | 14.00 | 14.04 |
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.